Clinical Core
Clinical Core
批准号:
10247455
负责人:
LON S SCHNEIDER
金额:
$119.36万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-02-28
关键词:
AddressAlzheimer disease preventionAlzheimer&aposs DiseaseArtsAutopsyBasic ScienceBiological MarkersBloodBlood VesselsCaliforniaCaregiver supportCaregiversCaringCerebrovascular systemClinicClinicalClinical DataClinical ResearchClinical TrialsCohort StudiesCollaborationsCollectionCommunitiesComprehensive Health CareDataData SetDatabasesDementiaDiagnosisDiseaseElderlyEngineeringEnrollmentEvaluationFundingGenerationsGoalsHuntington DiseaseImageImpaired cognitionIndividualInfrastructureInstitutesLatinxLeadershipLearningLettersLongitudinal cohortMagnetic Resonance ImagingMeasuresMedicalMedical ResearchMetabolicMolecularMonitorMulti-site clinical studyNeuropsychologyParticipantPathogenesisPathologicPatientsPhasePhysiciansPositron-Emission TomographyPostdoctoral FellowPreventionPuncture procedureResearchResearch InstituteResearch PersonnelResearch Project GrantsRiskRisk FactorsRoleScheduleSchoolsSpecimenSpinal PunctureTargeted ResearchTechnologyTranslational ResearchUnderrepresented PopulationsUnited States National Institutes of HealthVascular Cognitive ImpairmentVascular DiseasesVenipuncturesWorkbrain researchcaregivingcerebrovascularcohortcollegedata managementdata sharingdrug developmentearly phase clinical trialethnic diversityfunctional statushealth disparityimaging biomarkerindexingmedical schoolsneuroimagingneuropathologyneurovascular unitnew therapeutic targetnovelrecruitresearch studystatisticstooltrial designvascular contributionsvascular risk factorvolunteerwillingness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The Clinical Core serves the USC ADRC’s themes, cerebrovascular and metabolic contributions to cognitive
impairment; vascular and metabolic risk factors in cognitive decline; Alzheimer pathogenesis; and the prevention
and treatment of Alzheimer-related disorders. The Core’s three overarching objectives are to: 1) develop and
maintain a vascular risk factors cohort; 2) catalyze local, clinical and translational research, including early phase
clinical trials; 3) provide expertise in vascular disease, biomarkers, and imaging to national collaborative
initiatives. The Core addresses many important goals of the 2011 National Alzheimer Project Act (NAPA):
translational tools, infrastructure, trial design and conduct, novel drug targets, research on caregiver support,
recruitment and citizen engagement, biomarkers, health disparities, data sharing, and enabling technologies.
The Core enrolls and retains the primary ADRC cohorts, i.e., the Vascular Cohort Study, Brain Research
(autopsy) Study, and participants co-enrolled in Affiliated-Studies. The core performs standard evaluations and
diagnoses, oversees neuroimaging and blood and CSF biomarker collection. For this renewal, the core plans to
increase the vascular cohort, enrollment for autopsy, and Latinx participation; and continue to provide
infrastructure for over 25 ADRC-affiliated, independently-funded research studies including USC Investigator-
initiated NIH-funded clinical studies. The core is an integrated, collaborative team, including physicians (Lon
Schneider, Helena Chui, John Ringman, Elizabeth Joe, Sonia Pawluczyk), neuropsychologists (Lina D’Orazio,
Carol McCleary), and other investigators (Hussein Yassine, Judy Pa, Michael Harrington).
Its specific aims are to: 1) collaborate with the other ADRC cores to support the ADRC’s central theme by
recruiting and maintaining the vascular risk cohort; 2) recruit and maintain an ethnically diverse cohort focusing
on Latinx individuals and emphasizing vascular and metabolic risk, ADRC participation, and affiliated funded
studies; 3) recruit and maintain a the Brain Research Study cohort and work with other cores to share specimens;
4) perform annual NACC Uniform Data Set (UDS) evaluations, submit data to NACC, promote an integrated
national database, facilitate collaborative research and data sharing; 5) advance USC’s participation and
leadership in national collaborative studies by recruiting, retaining participants in ADRC-affiliated national and
multicenter projects; 6) enhance recruitment and promote dementia prevention efforts and translational research
opportunities in collaboration with the ORE core that particularly includes participants from Latinx and
underrepresented groups, and from the USC California-funded Alzheimer’s Disease Centers (CADC), and
Roybal Comprehensive Healthcare Clinic; and 7) support neuroimaging and biofluid biomarker studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
-
批准号:10655665
-
项目类别:
-
资助金额:$86.84万
-
财政年份:2020
-
负责人:LON S SCHNEIDER
-
依托单位:
Clinical Core
-
批准号:9922628
-
项目类别:
-
资助金额:$79.42万
-
财政年份:2020
-
负责人:LON S SCHNEIDER
-
依托单位:
Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve
-
批准号:8109764
-
项目类别:
-
资助金额:$56.12万
-
财政年份:2011
-
负责人:LON S SCHNEIDER
-
依托单位:
Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve
-
批准号:8447482
-
项目类别:
-
资助金额:$50.79万
-
财政年份:2011
-
负责人:LON S SCHNEIDER
-
依托单位:
Longer-term Alzheimer Disease Studies to Improve Clinical Trials Methods Outcomes
-
批准号:8245715
-
项目类别:
-
资助金额:$54.71万
-
财政年份:2011
-
负责人:LON S SCHNEIDER
-
依托单位:
Estrogen Receptor-beta phytoSERMs for Management of Menopause and Memory Decline
-
批准号:8279247
-
项目类别:
-
资助金额:$41.43万
-
财政年份:2010
-
负责人:LON S SCHNEIDER
-
依托单位:
Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated
-
批准号:7785854
-
项目类别:
-
资助金额:$68.67万
-
财政年份:2010
-
负责人:LON S SCHNEIDER
-
依托单位:
Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated
-
批准号:8079024
-
项目类别:
-
资助金额:$53.49万
-
财政年份:2010
-
负责人:LON S SCHNEIDER
-
依托单位:
Depression in Alzheimer's Disease Study 2 (DIADS-2)
-
批准号:7024574
-
项目类别:
-
资助金额:$11.93万
-
财政年份:2003
-
负责人:LON S SCHNEIDER
-
依托单位:
Depression in Alzheimer's Disease Study 2 (DIADS-2)
-
批准号:7184323
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2003
-
负责人:LON S SCHNEIDER
-
依托单位:
Depression in Alzheimer's Disease Study 2 (DIADS-2)
-
批准号:6868196
-
项目类别:
-
资助金额:$12.19万
-
财政年份:2003
-
负责人:LON S SCHNEIDER
-
依托单位:
Depression in Alzheimer's Disease Study 2 (DIADS-2)
-
批准号:6616542
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2003
-
负责人:LON S SCHNEIDER
-
依托单位:
Depression in Alzheimer's Disease Study 2 (DIADS-2)
-
批准号:6756389
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2003
-
负责人:LON S SCHNEIDER
-
依托单位:
CORE--PHARMACOLOGY
-
批准号:6267336
-
项目类别:
-
资助金额:$24.61万
-
财政年份:1998
-
负责人:LON S SCHNEIDER
-
依托单位:
CLINICAL CORE
-
批准号:8440482
-
项目类别:
-
资助金额:$73.16万
-
财政年份:1997
-
负责人:LON S SCHNEIDER
-
依托单位:
CORE--PHARMACOLOGY
-
批准号:6234088
-
项目类别:
-
资助金额:$24.05万
-
财政年份:1997
-
负责人:LON S SCHNEIDER
-
依托单位:
CARBAMAZEPINE TRIAL IN AGITATED ALZHEIMERS OUTPATIENTS
-
批准号:2248341
-
项目类别:
-
资助金额:$13.88万
-
财政年份:1992
-
负责人:LON S SCHNEIDER
-
依托单位:
CARBAMAZEPINE TRIAL IN AGITATED ALZHEIMERS OUTPATIENTS
-
批准号:2248342
-
项目类别:
-
资助金额:$5.7万
-
财政年份:1992
-
负责人:LON S SCHNEIDER
-
依托单位:
CARBAMAZEPINE TRIAL IN AGITATED ALZHEIMER'S OUTPATIENTS
-
批准号:3388264
-
项目类别:
-
资助金额:$13.88万
-
财政年份:1992
-
负责人:LON S SCHNEIDER
-
依托单位:
CARBAMAZEPINE TRIAL IN AGITATED ALZHEIMER'S OUTPATIENTS
-
批准号:3388265
-
项目类别:
-
资助金额:$13.35万
-
财政年份:1992
-
负责人:LON S SCHNEIDER
-
依托单位:
海外基金